Alyse Winchester Staley, MS

Sr. Research Scientist, Pediatrics-Endocrinology

Provider Credentials
Master of Science
Faculty Photo
Graduate School
  • MS, Colorado School of Public Health (2021)
Undergraduate School
  • BA, Pomona College (2017)
Department
Pediatrics-Endocrinology

Publications

  • Carroll MG, Mukhtar N, Calhoun J, Garza B, Loberg MA, Chen HC, Sheng Q, Staley A, Fonseca TL, Bianco AC, Ringel MD, Brock P, Gunderson AJ, Tarhini AA, Cress WD, Cavnar MJ, Edge S, Kaur V, Weiner GJ, Farlow JL, Dood R, Groisberg R, Naquash AR, Shriver C, Mudaranthakam DP, Oliveras JA, Rounbehler RJ, Churchman ML, Weiss VL, Schweppe RE, Pozdeyev N, Haugen BR. Type 2 Deiodinase in Cancer-Associated Fibroblasts: A Potential Therapeutic Target in Many Types of Cancer. medRxiv. 2026 Sep 21. PubMed PMID: 42818153
  • Nie Y, Staley A, Hinz TK, Perez-Johnston R, Merrick DT, Yang MC, Davies KD, Bunn PA, Aisner DL, Camidge DR, Schenk EL, Heasley LE, Patil T. High Programmed Death-Ligand 1 Expression is Associated With a Shorter Progression Free Survival in ALK-Rearranged Lung Cancer Patients Treated With First Line Tyrosine Kinase Inhibitors. Clin Lung Cancer. 2026 Jun;27(5):96-105. PubMed PMID: 42209337
  • Christenson JL, Spoelstra NS, Williams MM, Logan LL, O'Neill KI, Orlicky DJ, Baker NT, Wagner JA, Staley AW, Van Bokhoven A, Goodspeed A, Kuo LW, Crump LS, Diamond JR, Richer JK. Metastasis-Associated Wound Repair Promotes Reciprocal Lung Epithelium Activation and Breast Cancer Metastatic Outgrowth. Cancer Res Commun. 2026 Apr 1;6(4):750-768. PubMed PMID: 41937294
  • Callahan RC, Curry JC, Bhagavatula G, Staley AW, Schaefer RE, Minhajuddin F, Zhou L, Neuhart RM, Atif SM, Orlicky DJ, Cartwright IM, Gerich ME, Steiner CA, Theiss AL, Hall CH, Colgan SP, Onyiah JC. Epithelial HO-1 regulates iron availability and promotes colonic tumorigenesis in a context-dependent manner. JCI Insight. 2026 Feb 9;11(3). PubMed PMID: 41410530
  • Smith DC, Thumm EB, Giano Z, Staley A, Sheeder J, Barton AJ, Hernandez TL. Retrospective Cohort Study on Racial and Ethnic Disparities in Cesarean Birth in a Midwifery-Integrated Health System. J Obstet Gynecol Neonatal Nurs. 2026 May;55(3):278-286.e2. PubMed PMID: 41276260
  • Smith D, Thumm B, Giano Z, Staley A, Sheeder J, Barton A, Hernandez T. Evaluating Racial and Ethnic Differences in Use of Elective Labor Induction for Low-Risk Births: A Retrospective Cohort Study. J Perinat Neonatal Nurs. 2026 Jul-Sep 01;40(3):217-224. PubMed PMID: 40067924
  • Gu S, Staley AW, Mickael C, Sanders L, Lahm T, Stenmark KR. Distinct RV vs. LV Macrophage Stress Responses Under Uniform Hypoxia. Abstract presented at: Pulmonary Vascular Research Institute (PVRI) 2026; 2026 Jan 28-Feb 1; Dublin, Ireland.
  • Staley AW, Zhuang Y, Theiss A, Gu S, Gao D. Advanced Statistical Applications of MAST Models for Single-Cell RNA-seq Data. Abstract presented at: Bioinformatics Symposium, University of Colorado School of Medicine; 2026 Mar 4; Aurora, CO.
  • Boulton DP, Jordan KR, Staley A, Spoelstra N, Fornier M, Vidal GA, Rickert C, Elias AD, Richer JK. ORF11-05: The Impact of Androgen Receptors on ER+ Breast Cancer Microenvironments. ENDO 2026 [Internet]. 2026 Jun 13–16; Chicago, IL. Available 7 from:https://endo2026.endocrine.org/fsPopup.asp?PresentationID=1830459&mod e=presInfo
  • Mull M, Spoelstra N, Baker N, Christenson J, Staley A, Richer J. SUN-289: AR and ER Context-Dependent Dimerization in Breast Cancer. ENDO 2026 [Internet]. 2026 Jun 13–16; Chicago, IL. Available from: https://endo2026.endocrine.org/fsPopup.asp? PresentationID=1845804&mode=presInfo
  • Callahan RC, Curry JC, Bhagavatula G, Staley AW, Schaefer RE, Minhajuddin F, Zhou L, Neuhart RM, Atif SM, Orlicky DJ, Cartwright IM, Gerich ME, Steiner CA, Theiss AL, Hall CH, Colgan SP, Onyiah JC. Epithelial HO-1 regulates iron availability and promotes colonic tumorigenesis in a context-dependent manner. JCI Insight. 2025 Dec 17. [Epub ahead of print] PubMed PMID: 41410530
  • Smith DC, Thumm EB, Giano Z, Staley A, Sheeder J, Barton AJ, Hernandez TL. Retrospective Cohort Study on Racial and Ethnic Disparities in Cesarean Birth in a Midwifery-Integrated Health System. J Obstet Gynecol Neonatal Nurs. 2025 Nov 20. [Epub ahead of print] PubMed PMID: 41276260
  • Watson AS, Staley AW, Yoder B, Iwamoto SJ, Alami V, Schenk EL, Patil T, Camidge DR, Taormina JM. Early Weight Gain as a Risk Factor for Increased Maximum Weight Gain Among Patients With NSCLC on Lorlatinib and Other ALK Tyrosine Kinase Inhibitors. JTO Clin Res Rep. 2025 Sep;6(9):100870. PubMed PMID: 40800726
  • Smith D, Thumm B, Giano Z, Staley A, Sheeder J, Barton A, Hernandez T. Evaluating Racial and Ethnic Differences in Use of Elective Labor Induction for Low-Risk Births : A Retrospective Cohort Study. J Perinat Neonatal Nurs. 2025 Mar 11. [Epub ahead of print] PubMed PMID: 40067924
  • Winzent-Oonk S, Staley A, Alami V, Bradley J, Harvey S, Pounds A, Kuldanek S, Pacenta H, Winters AC, McKinney C. Risk of transfusion-related iron overload varies based on oncologic diagnosis and associated treatment: Retrospective analysis from a single pediatric cancer center. Pediatr Blood Cancer. 2025 Jan;72(1):e31254. PubMed PMID: 39118250
  • Sessions DT, Boulton DP, Spoelstra NS, Caino MC, Yu M, Goodspeed A, Richer JK. Androgen Receptors Promote Oxidative Phosphorylation and Resistance to Palmitate Lipotoxicity in ER-Mutant Breast Cancer. Endocrinology. 2025 Dec 5;167(1). PubMed PMID: 41216931
  • Christenson JL, Spoelstra NS, Williams MM, O'Neill KI, Orlicky DJ, Wagner JA, Goodspeed AE, Kuo LW, Crump LS, Richer JK. Metastasis-associated wound repair promotes reciprocal activation of the lung epithelium and breast cancer metastases during outgrowth. bioRxiv. 2025 Jul 27. PubMed PMID: 40777238
  • Richer J, Elias AD, Staley AW, Fornier M, Vidal GA, Alami V, Sams S, Spoelstra NS, Goodspeed A, Kabos P, Diamond JR, Shagisultanova E, Gallagher RI, Wulfkuhle J, Petricoin E, Zolman K, McSpadden T, Rickert C, Jordon KR, Slansky JE, Borges VF, Gao D. Abstract PS18-07: Differential odds of response in ILC versus IDC correlate with changes in the TIME in a phase II trial of pre-operative fulvestrant with or without enzalutamide. Clinical Cancer Research [Internet]. 2025 Jun 13;31(12_Supplement). Available from: http://dx.doi.org/10.1158/1557-3265.SABCS24-PS18-07
  • Watson AS, Staley AW, Yoder B, Iwamoto SJ, Schenk EL, Patil T, Camidge DR, Taormina JM. PP01.44. Real-World Risk Factors for ALK-Inhibitor Associated Weight Gain in Non-Small Cell Lung Cancer. International Association for the Study of Lung Cancer Targeted Therapies of Lung Cancer Conference [Internet]. 2025 Feb 18–22. Available from: https://airdrive.eventsair.com/eventsairsthcusprod/production-iaslc-public/925287e026e04fc78854a8c98ab51a19
  • Elias AD, Staley AW, Fornier M, Vidal GA, Alami V, Sams S, Spoelstra NS, Goodspeed A, Kabos P, Diamond JR, Shagisultanova E, Gallagher RI, Wulfkuhle JD, Petricoin EF, Zolman KL, McSpadden T, Jordan KR, Slansky JE, Borges VF, Gao D, Richer JK. Clinical and immune responses to neoadjuvant fulvestrant with or without enzalutamide in ER /Her2- breast cancer. NPJ Breast Cancer. 2024 Oct 6;10(1):88. PubMed PMID: 39368973
  • Winzent-Oonk S, Staley A, Alami V, Bradley J, Harvey S, Pounds A, Kuldanek S, Pacenta H, Winters AC, McKinney C. Risk of transfusion-related iron overload varies based on oncologic diagnosis and associated treatment: Retrospective analysis from a single pediatric cancer center. Pediatr Blood Cancer. 2024 Aug;72(1):e31254. PubMed PMID: 39118250
  • Tsui DCC, Holt DE, Patil T, Staley A, Gao D, Kavanagh BD, Schenk EL, Rusthoven CG, Camidge DR. The Role of Local Therapy for Oligo-Progressive Disease in Oncogene-Addicted Non-Small-Cell Lung Cancer. Adv Radiat Oncol. 2024 Jul;9(7):101516. PubMed PMID: 38868503
  • Callahan RC, Bhagavatula G, Curry J, Staley AW, Schaefer REM, Minhajuddin F, Zhou L, Neuhart R, Atif SM, Orlicky DJ, Cartwright IM, Gerich M, Theiss AL, Hall CHT, Colgan SP, Onyiah JC. Epithelial heme oxygenase-1 enhances colonic tumorigenesis by inhibiting ferroptosis. bioRxiv. 2024 Mar 8. PubMed PMID: 38496569
  • Patil T, Staley A, Nie Y, Sakamoto M, Stalker M, Jurica JM, Koehler K, Cass A, Kuykendall H, Schmitt E, Filar E, Reventaite E, Davies KD, Nijmeh H, Haag M, Yoder BA, Bunn PA, Schenk EL, Aisner DL, Iams WT, Marmarelis ME, Camidge DR. The Efficacy and Safety of Treating Acquired MET Resistance Through Combinations of Parent and MET Tyrosine Kinase Inhibitors in Patients With Metastatic Oncogene-Driven NSCLC. JTO Clin Res Rep. 2024 Feb;5(2):100637. PubMed PMID: 38361741
  • Smith DC, Thumm EB, Anderson J, Kissler K, Reed SM, Centi SM, Staley AW, Hernandez TL, Barton AJ. Sudden Shift to Telehealth in COVID-19: A Retrospective Cohort Study of Disparities in Use of Telehealth for Prenatal Care in a Large Midwifery Service. J Midwifery Womens Health. 2024 Jul-Aug;69(4):522-530. PubMed PMID: 38111228
  • Elias AD, Staley AW, Fornier M, Vidal GA, Alami V, Sams S, Spoelstra NS, Kabos P, Diamond JR, Shagisultanova E, Gallagher RI, Wulfkuhle J, Petricoin E, Zolman K, McSpadden T, Rickert C, Jordan KR, Slansky JE, Borges VF, Gao D, Richer JK. Abstract PS18-07: Differential odds of response in ILC versus IDC correlate with changes in the TIME in a phase II trial of pre-operative fulvestrant with or without enzalutamide. Poster session presented at: Proceedings of the 2024 San Antonio Breast Cancer Symposium; 2024 Dec 10-12; San Antonio, TX.
  • Nie Y, Staley A, Hinz T, Merrick D, Yang M, Schenk EL, Bunn PA, Camidge DR, Heasley L, Patil T. High PD-L1 expression among patients with ALK rearranged nonsmall cell lung cancer and response to first line ALK tyrosine kinase inhibitors. Journal of Clinical Oncology [Internet]. 2024 Jun 1;42(16_suppl):8626–8626. Available from: http://dx.doi.org/10.1200/JCO.2024.42.16_suppl.8626
  • DeMarsh SJ, Ackley ER, Staley A, Dorris KM. QOL-53. EXPLORING HEADACHES IN PEDIATRIC NEURO-ONCOLOGY PATIENTS: A SINGLE INSTITUTION RETROSPECTIVE CHART REVIEW. Neuro-Oncology [Internet]. 2024 Jun 18;26(Supplement_4):0–0. Available from: http://dx.doi.org/10.1093/neuonc/noae064.641
  • Elias AD, Spoelstra NS, Staley AW, Sams S, Crump LS, Vidal GA, Borges VF, Kabos P, Diamond JR, Shagisultanova E, Afghahi A, Mayordomo J, McSpadden T, Crawford G, D’Alessandro A, Zolman KL, Bokhoven A van, Zhuang Y, Gallagher RI, Wulfkuhle JD, Petricoin III EF, Gao D, Richer JK. Phase II trial of fulvestrant plus enzalutamide in ER+/HER2- advanced breast cancer. npj Breast Cancer [Internet]. 2023 May 20;9(1). Available from: http://dx.doi.org/10.1038/s41523-023-00544-z
  • Rusthoven CG, Staley AW, Gao D, Yomo S, Bernhardt D, Wandrey N, El Shafie R, Kraemer A, Padilla O, Chiang V, Faramand AM, Palmer JD, Zacharia BE, Wegner RE, Hattangadi-Gluth JA, Levy A, Bernstein K, Mathieu D, Cagney DN, Chan MD, Grills IS, Braunstein S, Lee CC, Sheehan JP, Kluwe C, Patel S, Halasz LM, Andratschke N, Deibert CP, Verma V, Trifiletti DM, Cifarelli CP, Debus J, Combs SE, Sato Y, Higuchi Y, Aoyagi K, Brown PD, Alami V, Niranjan A, Lunsford LD, Kondziolka D, Camidge DR, Kavanagh BD, Robin TP, Serizawa T, Yamamoto M. Comparison of first-line radiosurgery for small-cell and non-small cell lung cancer brain metastases (CROSS-FIRE). JNCI: Journal of the National Cancer Institute [Internet]. 2023 May 4;115(8):926–936. Available from: http://dx.doi.org/10.1093/jnci/djad073
  • Han DS, Walker JP, Nicklawsky A, Boxley P, Halstead NV, Tonzi M, Hecht SL, Staley A, Eguchi M, Cockburn MG, Roach JP, Saltzman AF, Cost NG. Pediatric Small Renal Masses: Can Tumor Size Predict Histology and the Potential for Nephron-sparing Surgery? Journal of Urology [Internet]. 2023 Mar;209(3):582–590. Available from: http://dx.doi.org/10.1097/JU.0000000000003092
  • Callahan R, Onyiah J, Bhagavatula G, Schaefer R, Staley A, Murphy E, Zhou L, Orlicky D, Atif S, Cartwright I, Hall C, Colgan S. Epithelial heme oxygenase-1 promotes colitis associated tumorigenesis through regulation of tumor epithelial differentiation and survival. Physiology [Internet]. 2023 May;38(S1). Available from: http://dx.doi.org/10.1152/physiol.2023.38.S1.5796045
  • Elias AD, Staley A, Fornier M, Vidal GA, Sams S, Spoelstra N, Kabos P, Diamond JR, Shagisultanova E, Gallagher RI, Wulfkuhle J, Petricoin E, Zolman K, Biller S, Alami V, McSpadden T, Borges V, Crump LS, Gao D, Richer JK. Abstract CT144: Randomized phase II trial of preoperative fulvestrant with or without enzalutamide for ER+/Her2- breast cancer. Cancer Research [Internet]. 2023 Apr 14;83(8_Supplement):CT144–CT144. Available from: http://dx.doi.org/10.1158/1538-7445.AM2023-CT144
  • Habenicht LM, Staley AW, Clancy BM, Bozan S, Manuel CA, Fong DL, Nicklawsky AG, Klug A, Leszczynski JK. Characterization of a Jumping Stereotypy in Gerbils (Meriones unguiculatus) and Assessment of Opaque Tubing Enrichment on Stereotypies and Breeding. J Am Assoc Lab Anim Sci. 2022 Mar 1;61(2):149-158. doi: 10.30802/AALAS-JAALAS-21-000101. Epub 2022 Feb 9. PubMed PMID: 35140007; PubMed Central PMCID: PMC8956210.
  • Jennifer K. Richer, Nicole S. Spoelstra, Alyse Winchester, Julia Wulfkuhle, Sharon B. Sams, Gregory Vidal, Peter Kabos, Jennifer Diamond, Elena Shagisultanova, Anosheh Afghahi, Jose Mayordomo, Tessa McSpadden, Gloria Crawford, Virginia Borges, Dexiang Gao, Emanuel Petricoin, Anthony D. Elias. Laboratory analyses of metastatic ER+/Her2- breast cancer treated with fulvestrant plus enzalutamide [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2021; 2021 Apr 10-15 and May 17-21. Philadelphia (PA): AACR; Cancer Res 2021;81(13_Suppl):Abstract nr 2867.
  • Denise Smith (Poster): Smith, D.C., Barton, A.J., Hernandez, T.L., Thumm, E.B., Willems, E.L., Staley, A.W., & Sheeder, J.L. (2022, May 22-26). Health system factors and racial and ethnic disparities in cesarean birth utilization among low-risk women. [Poster presentation]. American College of Nurse-Midwives, Chicago, IL
  • Denise Smith (Poster): Smith, D.C., Barton, A.J, Hernandez, T.L, Willems, E.L, Reed, S.M, Staley, A.W., Centi, S., & Anderson, J.L. (2022, May 22-26). The impact of a sudden shift to telehealth during the COVID19 pandemic on prenatal care and birth outcomes in a large nurse-midwifery service. [Poster presentation]. American College of Nurse-Midwives, Chicago, IL.
  • Elias A, Fornier M, Vidal G, Petricoin EF, Zolman K, Biller S, Alami V, Staley AW, McSpadden T, Borges VF, Gao D, Richer JF. Randomized phase II trial of preoperative fulvestrant with or without enzalutamide for ER+/Her2- breast cancer. Abstract ID: 1310755: Proceedings of the 2022 San Antonio Breast Cancer Symposium; 2022 Dec 6-10; San Antonio, Tx; American Association for Cancer Research; c2022
  • Richer J, Spoelstra N, Winchester A, Wulfkuhle J, Sams S, Vidal G, Kabos P, Diamond J, Shagisultanova E, Afghahi A, Mayordomo J, McSpadden T, Crawford G, Borges V, Gao D, Petricoin E, Elias A. Abstract 2867: Laboratory analyses of metastatic ER+/Her2- breast cancer treated with fulvestrant plus enzalutamide. Tumor Biology. Proceedings: AACR Annual Meeting 2021; April 10-15, 2021 and May 17-21, 2021; Philadelphia, PA; ; American Association for Cancer Research; c2021. Available from: http://cancerres.aacrjournals.org/lookup/doi/10.1158/1538-7445.AM2021-2867 DOI: 10.1158/1538-7445.AM2021-2867
  • Winchester AK, Peterson RA, Carter E, Sammel MD. Impact of COVID-19 Social Distancing Policies on Traffic Congestion, Mobility, and NO2 Pollution. Sustainability. 2021; 13(13):7275. https://doi.org/10.3390/su13137275
  • Afghahi A, Marsh S, Winchester A, Gao D, Parris H, Axell L, Ellisen L, Hofstatter E, Kurian A, Wood M, Zakalik D, Mullin C, Caswell-Jin J, Borges V, Tung N. Twenty-one-gene recurrence score (RS) in germline (g) CHEK2 mutation-associated versus sporadic breast cancers (BC): A multi-site case-control study. Journal of Clinical Oncology. 2021 May 20; 39(15_suppl):10531-10531. Available from: https://ascopubs.org/doi/10.1200/JCO.2021.39.15_suppl.10531 DOI: 10.1200/JCO.2021.39.15_suppl.10531
  • Jennifer K. Richer, Nicole S. Spoelstra, Alyse Winchester, Julia Wulfkuhle, Sharon B. Sams, Gregory Vidal, Peter Kabos, Jennifer Diamond, Elena Shagisultanova, Anosheh Afghahi, Jose Mayordomo, Tessa McSpadden, Gloria Crawford, Virginia Borges, Dexiang Gao, Emanuel Petricoin, Anthony D. Elias. Laboratory analyses of metastatic ER+/Her2- breast cancer treated with fulvestrant plus enzalutamide [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2021; 2021 Apr 10-15 and May 17-21. Philadelphia (PA): AACR; Cancer Res 2021;81(13_Suppl):Abstract nr 2867.
  • Elias A, Fournier M, Vidal G, Sams S, Spoelsta N, Kabos P, Diamond J, Shagisultanova E, Afghahi A, Mayordomo J, Wulfkuhle J, Petricoin E, Carter L, Zolman K, Armstead S, Winchester A, McSpadden T, Crawford G, Borges V, Gao D, Richer J. Abstract PS12-06: Phase II randomized trial of fulvestrant with or without enzalutamide in ER+/Her2- primary breast cancer (BC). Poster Session Abstracts. Abstracts: 2020 San Antonio Breast Cancer Virtual Symposium; December 8-11, 2020; San Antonio, Texas; ; American Association for Cancer Research; c2021. Available from: http://cancerres.aacrjournals.org/lookup/doi/10.1158/1538-7445.SABCS20-PS12-06 DOI: 10.1158/1538-7445.SABCS20-PS12-06
  • Anthony D Elias, Monica Fournier, Gregory A Vidal, Sharon Sams, Nicole Spoelsta, Peter Kabos, Jennifer R Diamond, Elena Shagisultanova, Anosheh Afghahi, Jose Mayordomo, Julia Wulfkuhle, Emanuel Petricoin, Lisa Carter, Kathryn Zolman, Stephanie Armstead, Alyse Winchester, Tessa McSpadden, Gloria Crawford, Virginia Borges, Dexiang Gao, Jennifer Richer. Phase II randomized trial of fulvestrant with or without enzalutamide in ER+/Her2- primary breast cancer (BC) [abstract]. In: Proceedings of the 2020 San Antonio Breast Cancer Virtual Symposium; 2020 Dec 8-11; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2021;81(4 Suppl):Abstract nr PS12-06.
  • Elias A, Spoelsta N, Vidal G, Sams S, Kabos P, Diamond J, Shagisultanova E, Afghahi A, Mayordomo J, McSpadden T, Crawford G, Carter L, Zolman K, Armstead S, Winchester A, Borges V, Wulfkuhle J, Petricoin E, Gao D, Richer J. Abstract PS12-14: Phase II trial of fulvestrant plus enzalutamide in ER+/Her2- advanced breast cancer. Poster Session Abstracts. Abstracts: 2020 San Antonio Breast Cancer Virtual Symposium; December 8-11, 2020; San Antonio, Texas; ; American Association for Cancer Research; c2021. Available from: http://cancerres.aacrjournals.org/lookup/doi/10.1158/1538-7445.SABCS20-PS12-14 DOI: 10.1158/1538-7445.SABCS20-PS12-14
  • Anthony D Elias, Nicole Spoelsta, Gregory A Vidal, Sharon Sams, Peter Kabos, Jennifer R Diamond, Elena Shagisultanova, Anosheh Afghahi, Jose Mayordomo, Tessa McSpadden, Gloria Crawford, Lisa Carter, Kathryn Zolman, Stephanie Armstead, Alyse Winchester, Virginia Borges, Julia Wulfkuhle, Emanuel Petricoin, Dexiang Gao, Jennifer Richer. Phase II trial of fulvestrant plus enzalutamide in ER+/Her2- advanced breast cancer [abstract]. In: Proceedings of the 2020 San Antonio Breast Cancer Virtual Symposium; 2020 Dec 8-11; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2021;81(4 Suppl):Abstract nr PS12-14.
  • Winchester A, Peterson R, Carter E, Sammel M. Impact of COVID-19 Social Distancing Policies on Traffic Congestion, Mobility, and NO2 Pollution. Sustainability. 2021 June 29; 13(13):7275-. Available from: https://www.mdpi.com/2071-1050/13/13/7275 DOI: 10.3390/su13137275
  • Anosheh Afghahi, Sydney Marsh, Alyse Winchester, Dexiang Gao, Hannah Parris, Lisen Axell, Leif W. Ellisen, Erin Wysong Hofstatter, Allison W. Kurian, Marie Wood, Dana Zakalik, Carol-Ann Mullin, Jennifer Lee Caswell-Jin, Virginia F. Borges, Nadine M. Tung. Twenty-one-gene recurrence score (RS) in germline (g)CHEK2 mutation-associated versus sporadic breast cancers (BC): A multi-site case-control study [abstract]. Journal of Clinical Oncology 2021 39:15_suppl, 10531-10531
  • Smith D, Thumm EB, Kissler K, Centi S, Anderson J, Reed S, Staley A, Hernandez T, Barton A. Sudden Shift to Telehealth in COVID-19: A Retrospective Cohort Study of Disparities in Use of Telehealth for Prenatal Care in a Large Midwifery Service. Journal of Midwifery and Women's Health [Internet]. Forthcoming 2023.
View All (49 Total) View Less

Practice Locations

Hospital Affiliation
  • Children's Hospital Colorado

School of Medicine

CU Anschutz

Fitzsimons Building

13001 East 17th Place

Campus Box C290

Aurora, CO 80045

303.724.5375

School
General
Students